American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2000 · 35 citations · 24 references
Life SciencesImmunologyPathologyInflammationInnate ImmunityMolecular ImmunologyAcute InflammationCytokine BiologyInflammatory Cell SignalingInflammatory PathologyInflammatory Response RegulationInflammatory SignalingAcute Inflammatory ResponseAcute-phase MediatorsInflammatory Pathway ModulationInflammatory Response GenesInterleukin-1 Family CytokinesInterleukin-mediated InflammationTransgenic MiceTumor Necrosis Factor Receptor 1 Signaling
A complete understanding of the role for endogenously produced interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and IL-1 receptor antagonist (IL-1ra) in the acute phase response to inflammation remains unknown. In the present studies, knockout mice lacking either a functional IL-1 type I receptor (IL-1RI(-/-)), a TNF type I receptor (TNFR-I(-/-)), or both IL-1 type I and TNF type I receptors (IL-1RI(-/-)/TNFR-I(-/-)) received a turpentine abscess. Additional mice deficient in IL-1ra protein (IL-1ra(-/-)) or overexpressing IL-1ra protein (IL-1ra(tg)) were similarly treated. After a turpentine abscess, IL-1 receptor knockout mice exhibited an attenuated inflammatory response compared with wild-type or animals lacking a functional TNFR-I. Mice overexpressing IL-1ra also had an attenuated hepatic acute phase protein response, whereas IL-1ra knockout mice had a significantly greater hepatic acute phase response. We conclude that the inflammatory response to a turpentine abscess is the result of a balance between IL-1ra expression and IL-1 binding to its type I receptor. Endogenously produced IL-1ra plays a central role in mitigating the magnitude of the IL-1-mediated inflammatory response and, ultimately, the outcome to a turpentine abscess.
24
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Manfred Köpf, Heinz Baumann, Giulia Freer et al. · Nature · 1994 · 1.8K citations
Life Sciences, Immunology, Pathology +16
Seijiro Okusawa, Jeffrey A. Gelfand, Takashi Ikejima et al. · Journal of Clinical Investigation · 1988 · 988 citations · Full text
Medicine, Immunology, Pharmacology +17
Reiko Horai, Masahide Asano, Katsuko Sudo et al. · The Journal of Experimental Medicine · 1998 · 615 citations · Full text